Methyl lucidone inhibits airway inflammatory response by reducing TAK1 activity in human bronchial epithelial NCI–H292 cells

Methyl lucidone inhibits airway inflammatory response by reducing TAK1 activity in human bronchial epithelial NCI–H292 cells

Background: Methyl lucidone (ML), a methyl derivative of lucidone, has anti-inflammatory properties. However, the molecular mechanisms that reduce the inflammatory effect of ML in human lung epithelial cells remain unkown. This study aimed to elucidate the molecular mechanisms underlying the anti-in...

Full description

Bibliographic Details
Main Authors: Eun Sol Oh, Hyunju Ro, Hyung Won Ryu, Yu Na Song, Ji-Yoon Park, Namho Kim, Hae-Young Kim, Seon Min Oh, Su-Yeon Lee, Doo-Young Kim, Sooil Kim, Sung-Tae Hong, Mun-Ock Kim, Su Ui Lee
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Heliyon
Subjects:
Methyl lucidone
Inflammatory lung disease
TAK1
NF-κB
p38 MAP kinase
Human bronchial epithelial cell
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023073620

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023073620

Similar Items